Literature DB >> 24894883

Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia.

Sarah K Keedy1, James L Reilly2, Jeffrey R Bishop3, Peter J Weiden4, John A Sweeney5.   

Abstract

BACKGROUND: Antipsychotic medications have established clinical benefit, but there are few neuroimaging studies before and after initiating antipsychotic medication to assess drug influence on brain circuitry. Attention and motor learning tasks are promising approaches for examining treatment-related changes in frontostriatal systems.
METHODS: Twenty-one unmedicated first-episode schizophrenia patients (14 antipsychotic-naïve) participated in functional imaging studies while performing visual attention (prosaccades) and motor learning tasks (predictive saccades). Posttreatment testing was completed in 14 patients after 4-6 weeks of antipsychotic treatment. Matched healthy controls were studied in parallel.
RESULTS: Pretreatment, patients had reduced activation in the dorsal neocortical visual attention network. Activation deficits were significantly reduced posttreatment. Higher medication dose was associated with greater caudate activation at follow-up. For the motor learning task, patients' dorsolateral prefrontal cortex (DLPFC) was unimpaired prior to treatment but showed significantly reduced activation after treatment.
CONCLUSION: Impairments in dorsal cortical attention networks are present in untreated first-episode schizophrenia patients. These impairments are reduced after antipsychotic treatment, suggesting a beneficial effect on neural systems for attention. Treatment-emergent decreases in DLPFC activation observed for the motor learning task are consistent with other clinical and preclinical evidence suggesting that antipsychotics can have adverse effects on prefrontal function.
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  caudate; cognition; dorsolateral prefrontal cortex; fMRI; risperidone; saccades

Mesh:

Substances:

Year:  2014        PMID: 24894883      PMCID: PMC4332935          DOI: 10.1093/schbul/sbu071

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  52 in total

1.  Stimulus-response incompatibility activates cortex proximate to three eye fields.

Authors:  E P Merriam; C L Colby; K R Thulborn; B Luna; C R Olson; J A Sweeney
Journal:  Neuroimage       Date:  2001-05       Impact factor: 6.556

2.  Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.

Authors:  Anissa Abi-Dargham; Xiaoyan Xu; Judy L Thompson; Roberto Gil; Lawrence S Kegeles; Nina Urban; Raj Narendran; Dah-Ren Hwang; Marc Laruelle; Mark Slifstein
Journal:  J Psychopharmacol       Date:  2011-07-18       Impact factor: 4.153

3.  Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.

Authors:  Su Lui; Tao Li; Wei Deng; Lijun Jiang; Qizhu Wu; Hehan Tang; Qiang Yue; Xiaoqi Huang; Raymond C Chan; David A Collier; Shashwath A Meda; Godfrey Pearlson; Andrea Mechelli; John A Sweeney; Qiyong Gong
Journal:  Arch Gen Psychiatry       Date:  2010-08

4.  White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia.

Authors:  Meina Quan; Sang-Hyuk Lee; Marek Kubicki; Zora Kikinis; Yogesh Rathi; Larry J Seidman; Raquelle I Mesholam-Gately; Jill M Goldstein; Robert W McCarley; Martha E Shenton; James J Levitt
Journal:  Schizophr Res       Date:  2013-02-13       Impact factor: 4.939

5.  Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change.

Authors:  E T C Ngan; C J Lane; T J Ruth; P F Liddle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

6.  Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: implications for pursuit eye tracking.

Authors:  Rebekka Lencer; Sarah K Keedy; James L Reilly; Bruce E McDonough; Margret S H Harris; Andreas Sprenger; John A Sweeney
Journal:  Psychiatry Res       Date:  2011-08-27       Impact factor: 3.222

7.  Neural correlates of refixation saccades and antisaccades in normal and schizophrenia subjects.

Authors:  Jennifer E McDowell; Gregory G Brown; Martin Paulus; Antigona Martinez; Sara E Stewart; David J Dubowitz; David L Braff
Journal:  Biol Psychiatry       Date:  2002-02-01       Impact factor: 13.382

Review 8.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

9.  The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states.

Authors:  Patricia Westmoreland Corson; Daniel S O'Leary; Del D Miller; Nancy C Andreasen
Journal:  Biol Psychiatry       Date:  2002-11-01       Impact factor: 13.382

10.  Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study.

Authors:  Dieter F Braus; Wolfgang Weber-Fahr; Heike Tost; Matthias Ruf; Fritz A Henn
Journal:  Arch Gen Psychiatry       Date:  2002-08
View more
  13 in total

1.  Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder.

Authors:  Sarah K Keedy; Jeffrey R Bishop; Peter J Weiden; John A Sweeney; Cherise Rosen; Robert Marvin; James L Reilly
Journal:  Schizophr Res       Date:  2014-08-08       Impact factor: 4.939

2.  Nicotine restores functional connectivity of the ventral attention network in schizophrenia.

Authors:  Jason Smucny; Ann Olincy; Jason R Tregellas
Journal:  Neuropharmacology       Date:  2016-04-13       Impact factor: 5.250

3.  Pharmacokinetic patterns of risperidone-associated adverse drug reactions.

Authors:  Georgios Schoretsanitis; Benedikt Stegmann; Christoph Hiemke; Gerhard Gründer; Koen R J Schruers; Sebastian Walther; Sarah E Lammertz; Ekkehard Haen; Michael Paulzen
Journal:  Eur J Clin Pharmacol       Date:  2016-07-04       Impact factor: 2.953

Review 4.  Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies.

Authors:  Thérèse van Amelsvoort; Dennis Hernaus
Journal:  Front Psychiatry       Date:  2016-05-18       Impact factor: 4.157

Review 5.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies.

Authors:  Chengmin Yang; Jing Tang; Naici Liu; Li Yao; Mengyuan Xu; Hui Sun; Bo Tao; Qiyong Gong; Hengyi Cao; Wenjing Zhang; Su Lui
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

6.  Towards Clinically Relevant Oculomotor Biomarkers in Early Schizophrenia.

Authors:  Fotios Athanasopoulos; Orionas-Vasilis Saprikis; Myrto Margeli; Christoph Klein; Nikolaos Smyrnis
Journal:  Front Behav Neurosci       Date:  2021-06-10       Impact factor: 3.558

7.  Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.

Authors:  Seenae Eum; S Kristian Hill; Ney Alliey-Rodriguez; James M Stevenson; Leah H Rubin; Adam M Lee; Lauren J Mills; James L Reilly; Rebekka Lencer; Sarah K Keedy; Elena Ivleva; Richard S E Keefe; Godfrey D Pearlson; Brett A Clementz; Carol A Tamminga; Matcheri S Keshavan; Elliot S Gershon; John A Sweeney; Jeffrey R Bishop
Journal:  Neuropsychopharmacology       Date:  2021-06-18       Impact factor: 8.294

Review 8.  Current understandings about cognition and the neurobiological correlates in schizophrenia.

Authors:  Sujita Kumar Kar; Meha Jain
Journal:  J Neurosci Rural Pract       Date:  2016 Jul-Sep

9.  Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.

Authors:  Henrik Nørbak-Emig; Bjørn H Ebdrup; Birgitte Fagerlund; Claus Svarer; Hans Rasmussen; Lars Friberg; Peter N Allerup; Egill Rostrup; Lars H Pinborg; Birte Y Glenthøj
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-29       Impact factor: 5.176

10.  Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone.

Authors:  Nina Vanessa Kraguljac; David Matthew White; Jennifer Ann Hadley; Kristina Visscher; David Knight; Lawrence ver Hoef; Blessing Falola; Adrienne Carol Lahti
Journal:  Neuroimage Clin       Date:  2015-11-22       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.